Dr Claudia R Picone, MD - Medicare Hospitalist in Bangor, ME

Dr Claudia R Picone, MD is a medicare enrolled "Hospitalist" physician in Bangor, Maine. She went to University Of Pittsburgh School Of Medicine and graduated in 1993 and has 31 years of diverse experience with area of expertise as Hospitalist. She is a member of the group practice Mainehealth, Maine Medical Partners and her current practice location is 489 State St, Bangor, Maine. You can reach out to her office (for appointments etc.) via phone at (207) 973-7000.

Dr Claudia R Picone is licensed to practice in Maine (license number 015691) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1720193469.

Contact Information

Dr Claudia R Picone, MD
489 State St,
Bangor, ME 04401-6616
(207) 973-7000
(207) 973-5042



Physician's Profile

Full NameDr Claudia R Picone
GenderFemale
SpecialityHospitalist
Experience31 Years
Location489 State St, Bangor, Maine
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Claudia R Picone attended and graduated from University Of Pittsburgh School Of Medicine in 1993
  NPI Data:
  • NPI Number: 1720193469
  • Provider Enumeration Date: 08/21/2006
  • Last Update Date: 09/21/2011
  Medicare PECOS Information:
  • PECOS PAC ID: 0941241731
  • Enrollment ID: I20120227000108

Medical Identifiers

Medical identifiers for Dr Claudia R Picone such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1720193469NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist 015691 (Maine)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Maine Medical CenterPortland, MEHospital
Franklin Memorial HospitalFarmington, MEHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Mainehealth75178605882067
Maine Medical Partners9335043967789

News Archive

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Microscopic amounts of blood in urine have been considered a risk factor for urinary tract malignant tumors. However, only a small proportion of patients referred for investigation are subsequently found to have cancer. A new Kaiser Permanente Southern California study published in the February Mayo Clinic Proceedings reports on the development and testing of a Hematuria Risk Index to predict cancer risk.

Macrogenics, CMC Biologics sign agreement to develop oncology product candidate

CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into an agreement to further develop the production process for transfer and clinical manufacturing of one of MacroGenics' product candidates.

College students may be ignoring the threat of heart disease

In a groundbreaking study, a former Arizona State University student found college students may be ignoring the threat of heart disease and putting themselves at risk.

SapC-DOPS technology: New way to image glioblastoma multiforme tumors

Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.

The Ensign Group announces the acquisition of Golden Acres

The Ensign Group, Inc., announced today that it has acquired Golden Acres, an operating skilled nursing and independent living campus, as well as a separate hospice business, both in Dallas, Texas. The acquisition was effective October 1, 2009.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Claudia R Picone allows following entities to bill medicare on her behalf.
Entity NameStephens Memorial Hospital Association
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346299815
PECOS PAC ID: 8921990193
Enrollment ID: O20040602000734

News Archive

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Microscopic amounts of blood in urine have been considered a risk factor for urinary tract malignant tumors. However, only a small proportion of patients referred for investigation are subsequently found to have cancer. A new Kaiser Permanente Southern California study published in the February Mayo Clinic Proceedings reports on the development and testing of a Hematuria Risk Index to predict cancer risk.

Macrogenics, CMC Biologics sign agreement to develop oncology product candidate

CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into an agreement to further develop the production process for transfer and clinical manufacturing of one of MacroGenics' product candidates.

College students may be ignoring the threat of heart disease

In a groundbreaking study, a former Arizona State University student found college students may be ignoring the threat of heart disease and putting themselves at risk.

SapC-DOPS technology: New way to image glioblastoma multiforme tumors

Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.

The Ensign Group announces the acquisition of Golden Acres

The Ensign Group, Inc., announced today that it has acquired Golden Acres, an operating skilled nursing and independent living campus, as well as a separate hospice business, both in Dallas, Texas. The acquisition was effective October 1, 2009.

Read more Medical News

› Verified 8 days ago

Entity NameMainehealth
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1790265502
PECOS PAC ID: 7517860588
Enrollment ID: O20040701000166

News Archive

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Microscopic amounts of blood in urine have been considered a risk factor for urinary tract malignant tumors. However, only a small proportion of patients referred for investigation are subsequently found to have cancer. A new Kaiser Permanente Southern California study published in the February Mayo Clinic Proceedings reports on the development and testing of a Hematuria Risk Index to predict cancer risk.

Macrogenics, CMC Biologics sign agreement to develop oncology product candidate

CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into an agreement to further develop the production process for transfer and clinical manufacturing of one of MacroGenics' product candidates.

College students may be ignoring the threat of heart disease

In a groundbreaking study, a former Arizona State University student found college students may be ignoring the threat of heart disease and putting themselves at risk.

SapC-DOPS technology: New way to image glioblastoma multiforme tumors

Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.

The Ensign Group announces the acquisition of Golden Acres

The Ensign Group, Inc., announced today that it has acquired Golden Acres, an operating skilled nursing and independent living campus, as well as a separate hospice business, both in Dallas, Texas. The acquisition was effective October 1, 2009.

Read more Medical News

› Verified 8 days ago

Entity NameMaine Medical Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073527388
PECOS PAC ID: 9335043967
Enrollment ID: O20050401000844

News Archive

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Microscopic amounts of blood in urine have been considered a risk factor for urinary tract malignant tumors. However, only a small proportion of patients referred for investigation are subsequently found to have cancer. A new Kaiser Permanente Southern California study published in the February Mayo Clinic Proceedings reports on the development and testing of a Hematuria Risk Index to predict cancer risk.

Macrogenics, CMC Biologics sign agreement to develop oncology product candidate

CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into an agreement to further develop the production process for transfer and clinical manufacturing of one of MacroGenics' product candidates.

College students may be ignoring the threat of heart disease

In a groundbreaking study, a former Arizona State University student found college students may be ignoring the threat of heart disease and putting themselves at risk.

SapC-DOPS technology: New way to image glioblastoma multiforme tumors

Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.

The Ensign Group announces the acquisition of Golden Acres

The Ensign Group, Inc., announced today that it has acquired Golden Acres, an operating skilled nursing and independent living campus, as well as a separate hospice business, both in Dallas, Texas. The acquisition was effective October 1, 2009.

Read more Medical News

› Verified 8 days ago

Entity NameSound Physicians Of Massachusetts Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1205164951
PECOS PAC ID: 2062554637
Enrollment ID: O20150505000441

News Archive

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Microscopic amounts of blood in urine have been considered a risk factor for urinary tract malignant tumors. However, only a small proportion of patients referred for investigation are subsequently found to have cancer. A new Kaiser Permanente Southern California study published in the February Mayo Clinic Proceedings reports on the development and testing of a Hematuria Risk Index to predict cancer risk.

Macrogenics, CMC Biologics sign agreement to develop oncology product candidate

CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into an agreement to further develop the production process for transfer and clinical manufacturing of one of MacroGenics' product candidates.

College students may be ignoring the threat of heart disease

In a groundbreaking study, a former Arizona State University student found college students may be ignoring the threat of heart disease and putting themselves at risk.

SapC-DOPS technology: New way to image glioblastoma multiforme tumors

Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.

The Ensign Group announces the acquisition of Golden Acres

The Ensign Group, Inc., announced today that it has acquired Golden Acres, an operating skilled nursing and independent living campus, as well as a separate hospice business, both in Dallas, Texas. The acquisition was effective October 1, 2009.

Read more Medical News

› Verified 8 days ago

Entity NameSound Physicians Of New York Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174962245
PECOS PAC ID: 8628202231
Enrollment ID: O20151230001322

News Archive

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Microscopic amounts of blood in urine have been considered a risk factor for urinary tract malignant tumors. However, only a small proportion of patients referred for investigation are subsequently found to have cancer. A new Kaiser Permanente Southern California study published in the February Mayo Clinic Proceedings reports on the development and testing of a Hematuria Risk Index to predict cancer risk.

Macrogenics, CMC Biologics sign agreement to develop oncology product candidate

CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into an agreement to further develop the production process for transfer and clinical manufacturing of one of MacroGenics' product candidates.

College students may be ignoring the threat of heart disease

In a groundbreaking study, a former Arizona State University student found college students may be ignoring the threat of heart disease and putting themselves at risk.

SapC-DOPS technology: New way to image glioblastoma multiforme tumors

Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.

The Ensign Group announces the acquisition of Golden Acres

The Ensign Group, Inc., announced today that it has acquired Golden Acres, an operating skilled nursing and independent living campus, as well as a separate hospice business, both in Dallas, Texas. The acquisition was effective October 1, 2009.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Claudia R Picone is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Claudia R Picone, MD
43 Whiting Hill Rd, Ste 300,
Brewer, ME 04412-1005

Ph: (207) 973-5035
Dr Claudia R Picone, MD
489 State St,
Bangor, ME 04401-6616

Ph: (207) 973-7000

News Archive

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Microscopic amounts of blood in urine have been considered a risk factor for urinary tract malignant tumors. However, only a small proportion of patients referred for investigation are subsequently found to have cancer. A new Kaiser Permanente Southern California study published in the February Mayo Clinic Proceedings reports on the development and testing of a Hematuria Risk Index to predict cancer risk.

Macrogenics, CMC Biologics sign agreement to develop oncology product candidate

CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into an agreement to further develop the production process for transfer and clinical manufacturing of one of MacroGenics' product candidates.

College students may be ignoring the threat of heart disease

In a groundbreaking study, a former Arizona State University student found college students may be ignoring the threat of heart disease and putting themselves at risk.

SapC-DOPS technology: New way to image glioblastoma multiforme tumors

Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.

The Ensign Group announces the acquisition of Golden Acres

The Ensign Group, Inc., announced today that it has acquired Golden Acres, an operating skilled nursing and independent living campus, as well as a separate hospice business, both in Dallas, Texas. The acquisition was effective October 1, 2009.

Read more News

› Verified 8 days ago


Hospitalist Doctors in Bangor, ME

Dr. Leonard C Moneke, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 489 State St, Bangor, ME 04401
Phone: 207-973-7000    Fax: 207-973-5042
Dr. James M Mccarthy, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 489 State St, Bangor, ME 04401
Phone: 207-973-7000    Fax: 207-973-5042
Dr. Alexandra Craig, MD
Hospitalist
Medicare: Not Enrolled in Medicare
Practice Location: 992 Union St, Bangor, ME 04401
Phone: 207-945-5247    
Dr. Savitha Rajan, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 489 State St, Bangor, ME 04401
Phone: 207-973-7000    Fax: 207-973-5042
Pradeep S Paul, M.D.
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 360 Broadway, Bangor, ME 04401
Phone: 207-907-3215    Fax: 207-907-1795
Toyiba Hussain Syed, M.D.
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 489 State St, Bangor, ME 04401
Phone: 207-973-6252    Fax: 207-973-5042
Keith Amit Singh, MD
Hospitalist
Medicare: Medicare Enrolled
Practice Location: 489 State St, Bangor, ME 04401
Phone: 207-973-6605    Fax: 207-973-4441

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.